Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
6 hedge funds and large institutions have $2.1M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
1,661% more capital inflows, than outflows
Capital inflows: $526K | Capital outflows: $29.8K
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
1.83% more ownership
Funds ownership: 10.19% → 12.02% (+1.8%)
14% less funds holding
Funds holding: 7 → 6 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTS Securities
Miami,
Florida
|
+$282K |
| 2 |
Jane Street
New York
|
+$220K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18.4K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$11K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$397 |
| 4 |
Morgan Stanley
New York
|
-$38 |
PILL Hedge Fund Activity: Q3 2026 in Review
6 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2026, worth a combined $2.1M — up 8.7% from $1.93M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PILL and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was GTS Securities, adding an estimated $282K. The largest seller was UBS Group, exiting entirely with an estimated $18.4K sold.
- 6 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2026, down from 7 in Q2 2026.
- Funds reported $2.1M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2026, up 8.7% quarter-over-quarter.
- 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2026 and 3 closed out, a net change of -1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q3 2026 was GTS Securities, an estimated $282K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2026 was UBS Group, an estimated $18.4K sold.
Based on aggregated 13F filings for Q3 2026.